Sensei Biotherapeutics
SNSE • NASDAQ
Sensei Biotherapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Christopher W. Gerry, with a market cap of $11.2M.
CEOChristopher W. Gerry
Market Cap$11.2M
Biotechnology
Healthcare
Employees28.0
Websitesenseibio.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Sensei Biotherapeutics
Date
Tuesday, May 5, 2026 (in 3 months)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$4.81
Earnings History
Past 11 earnings reports for Sensei Biotherapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Q3 2025 | -$3.62Est: -$4.11 | +11.9% | - | — |  10-Q |
| Aug 5, 2025 | Q2 2025 | -$3.91Est: -$5.48 | +28.6% | - | — | 10-Q |
| May 6, 2025 | Q1 2025 | -$0.27Est: -$0.21 | -28.6% | - | — | 10-Q |
| Mar 28, 2025 | Q4 2024 | -$0.31Est: -$0.30 | -3.3% | - | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.29Est: -$0.31 | +6.5% | - | — | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$0.28Est: -$0.29 | +3.4% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.32Est: -$0.27 | -18.5% | - | — | 10-Q |
| Feb 28, 2024 | Q4 2023 | -$0.30Est: -$0.31 | +3.2% | - | — | 10-K |
| Nov 7, 2023 | Q3 2023 | -$0.28Est: -$0.34 | +17.6% | - | — | — |
| Aug 3, 2023 | Q2 2023 | -$0.31Est: -$0.33 | +6.1% | - | — | 10-Q |
| May 9, 2023 | Q1 2023 | -$0.33Est: -$0.36 | +8.3% | - | — | 10-Q |